Eleos Health vs Mentalyc
The category's clearest enterprise against solo split, and it trades published evidence against published privacy. Eleos is the enterprise platform with the deepest evidence base of any documentation adjacent vendor here, a randomised trial plus a 2.83 million micro dialogue accuracy study, the broadest setting coverage including substance use disorder and field care, and a checkable 80 percent acceptance rate. Its gaps are commercial and disclosural: gated pricing, and no located security attestation or data stewardship position. Mentalyc is the solo priced tool that carries exactly what Eleos lacks, a completed SOC 2 Type II, HIPAA and PHIPA, and an explicit commitment not to train on client data or retain recordings, the disclosures that matter most for therapy audio. If you are an enterprise behavioral health organisation that needs published evidence and broad coverage, start with Eleos. If you are a solo or small practice where data stewardship and transparent pricing decide it, start with Mentalyc.
- The deepest published evidence base of any documentation adjacent vendor in the index, graded A: a randomised clinical trial in the Journal of Medical Internet Research, a machine learning study on homework assignment, and a real world accuracy study across more than 2.83 million micro dialogues, where Mentalyc has no peer reviewed study located and grades C.
- The broadest coverage in the category, graded A on setting: behavioral health, substance use disorder treatment, and home health across office, telehealth, and field based settings, serving clinicians, supervisors, leadership, and compliance teams, where Mentalyc stays within outpatient psychotherapy.
- A checkable autonomy claim, graded A: the company publishes an approximate 80 percent suggestion acceptance rate, quantifying how much human correction the workflow requires, where Mentalyc publishes no edit burden figure.
- The strongest data stewardship in behavioral health, graded A: Mentalyc states plainly it does not train on client data and does not retain recordings, the specific commitments Eleos does not publish, leaving Eleos unrated on PHI stewardship.
- A completed security attestation and jurisdictional compliance, graded A: SOC 2 Type II plus HIPAA and PHIPA for Canada, where Eleos has no located third party attestation.
- Published solo to group pricing with no sales gate, graded A on commercial transparency, where Eleos gates pricing and grades C, and recording is optional across multiple input methods.
Side-by-Side
| Axis | E Eleos Health |
M Mentalyc |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
These sit at opposite ends of the category and serve different buyers, which makes the comparison unusually clean. Eleos is the enterprise platform whose distinguishing feature is genuine published clinical evidence, including a randomised trial that is rare anywhere in this index, though a buyer should carry the caveat that the RCT is small at 47 participants and single site, a feasibility study whose headline multiples are quoted in marketing without that qualifier. Mentalyc is the solo priced tool whose distinguishing feature is the clearest privacy and security posture in behavioral health, the completed SOC 2 Type II and the explicit no training and no retention stance Eleos lacks. That is the surprising inversion in this category: the cheaper tool carries the stronger attestations while the enterprise platform carries the stronger evidence. Both grade C on governance for unexamined speech model performance.